Moleculin Biotech, Inc.
$0.77
-$0.01 (-0.88%)
$0.75Day Range$0.80
Key Statistics
Market Cap
$15.19M
Shares Outstanding
19.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 2, 2016
Round Lot
100
Locale
US
Trading Data
Day Open
$0.78
Day High
$0.80
Day Low
$0.75
Volume
466.3K
VWAP
$0.77
Prev Close
$0.78
Transactions
--
Acc. Volume
--
About Moleculin Biotech, Inc.
Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.
PHARMACEUTICAL PREPARATIONSSIC 283417 employees5300 MEMORIAL DRIVE, HOUSTON, TX, 77007713-300-5160IPO Jun 2, 2016US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001659617
- Composite FIGI
- BBG00B9T47L9
- Share Class FIGI
- BBG00B9T47N7
- Ticker Root
- MBRX
- SIC Code
- 2834
About Moleculin Biotech, Inc. (MBRX) Stock
Moleculin Biotech, Inc. (MBRX) closed the 2026-09-18 session at $0.77, down 0.88% versus the previous close (-0.01). The stock opened at $0.78 and traded between $0.75 and $0.80 during that session. Session trading volume was 466K shares. The volume-weighted average price (VWAP) is $0.77.
Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.
Moleculin Biotech, Inc. has a market capitalization of $15.2 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. MBRX is listed on the XNAS exchange. The company employs approximately 17 people. Moleculin Biotech, Inc. is headquartered in HOUSTON, TX. The recorded listing date is 2016-06-02.
On this page you can find market MBRX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.